Hemato Oncology Testing Market Is Growing at US$ 23.64 Billion By 2033

Rising at a CAGR of 18.5%, the global hemato oncology testing market is projected to increase from a valuation of US$ 4.33 billion in 2023 to US$ 23.64 billion by the end of 2033. Hematology oncology tests are further classified into services, assay kits & reagents. Global demand for assay kits & reagents is expected to increase at an impressive CAGR of 20% from 2023 to 2033.

Assay kits are used in various applications, including examining disease pathways, screening for prospective drug candidates, and analyzing biopharmaceutical production processes, drug discovery & development, life science research, and environmental monitoring. A reagent, also known as an analytical reagent, is a substance or compound that is added to a system in chemistry to bring about a chemical reaction or check to see whether a reaction happens. Although the terms 'reagent' and 'reactant' are frequently used synonymously, reactant refers to a material that is consumed during a chemical reaction.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗥𝗘𝗘 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=8235?PJ

This Hemato Oncology Testing Market report comes with little company outline, earnings dialog, advantage, latest events and product offering, and ways of these gamers. The maturation of the substantial associations alongside their resources such as development, price, and customer satisfaction are gleaned from your analysis document about the International Hemato Oncology Testing Market. From the provider's particular needs, we may even provide customization for International Hemato Oncology Testing Market together with most of the info that is chosen.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Key players in the hemato oncology testing market are focused on developing advanced testing technologies. The sector is competitive and to maintain their market position leading companies are adopting strategies such as collaborations, mergers, new product launches, and more.

For instance, the Mount Sinai Million Health Discoveries Program, a new human genome sequencing research initiative with the Regeneron Genetics Center (RGC), was launched in August 2022 by Mount Sinai Health System and the Icahn School of Medicine. The RGC's extensive gene sequencing capabilities and scientific research know-how is planned to be combined with Mount Sinai's huge and diversified patient population by the collaborative team.

The iHope Genetic Health programme, which was launched in November 2021 by SAN DIEGO and Genetic Alliance, aims to give tens of thousands of people affected by genetic disorder access to whole-genome sequencing (WGS).

To provide accessibility to precision oncology biomarker testing, Thermo Fisher Scientific introduced CE-IVD (IVDD) next-generation sequencing test and analytic software in August 2022.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱

Abbott Laboratories
Adaptive Biotechnologies
Archerdx, Inc.
Arup Laboratories, Inc.
Asuragen, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffman-La Roche Ltd.
Illumina, Inc.
Invivoscribe, Inc.
Molecularmd (Subsidiary of Icon PLC)
Qiagen N.V.
Sanofi SA
Thermo Fisher Scientific, Inc.

By 2030, cancer cases are expected to increase to around 11 million in Asia, which already bears half of the world's burden of cancer. The increase is most likely the result of a population that is quickly getting older and is more prone to experience chronic disorders. Lung, blood, stomach, and liver cancers are among the most typical kinds of disease experienced in the region by the population.

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝗛𝗲𝗺𝗮𝘁𝗼 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

𝗕𝘆 𝗖𝗼𝗺𝗽𝗼𝗻𝗲𝗻𝘁 :
Services
Assay Kits & Reagents

𝗕𝘆 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 :
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Cytogenetics

𝗕𝘆 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝘆𝗽𝗲 :
Leukemia
Lymphoma
Hodgkin Lymphoma
Myeloproliferative Neoplasms

𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿 :
Hospitals
Academic & Research Institutes
Clinical Laboratories

𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻 :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:https://www.factmr.com/connectus/sample?flag=S&rep_id=8235?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.